BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31319405)

  • 1. Effects of Progressive Resistance Training on Obesity Indices in Polycystic Ovary Syndrome and the Relationship With Telomere Length.
    Kogure GS; Miranda-Furtado CL; Pedroso DCC; Ribeiro VB; Eiras MC; Silva RC; Caetano LC; Ferriani RA; Calado RT; Dos Reis RM
    J Phys Act Health; 2019 Aug; 16(8):601-607. PubMed ID: 31319405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nonrandomized Trial of Progressive Resistance Training Intervention in Women With Polycystic Ovary Syndrome and Its Implications in Telomere Content.
    Miranda-Furtado CL; Ramos FK; Kogure GS; Santana-Lemos BA; Ferriani RA; Calado RT; Dos Reis RM
    Reprod Sci; 2016 May; 23(5):644-54. PubMed ID: 26586671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance Exercise Impacts Lean Muscle Mass in Women with Polycystic Ovary Syndrome.
    Kogure GS; Miranda-Furtado CL; Silva RC; Melo AS; Ferriani RA; De Sá MF; Dos Reis RM
    Med Sci Sports Exerc; 2016 Apr; 48(4):589-98. PubMed ID: 26587847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Aerobic Exercise Did Not Change Telomere Length While It Reduced Testosterone Levels and Obesity Indexes in PCOS: A Randomized Controlled Clinical Trial Study.
    Ribeiro VB; Pedroso DCC; Kogure GS; Lopes IP; Santana BA; Dutra de Souza HC; Ferriani RA; Calado RT; Furtado CLM; Reis RMD
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperandrogenism Enhances Muscle Strength After Progressive Resistance Training, Independent of Body Composition, in Women With Polycystic Ovary Syndrome.
    Kogure GS; Silva RC; Miranda-Furtado CL; Ribeiro VB; Pedroso DCC; Melo AS; Ferriani RA; Reis RMD
    J Strength Cond Res; 2018 Sep; 32(9):2642-2651. PubMed ID: 29927897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome.
    Velazquez ME; Millan AL; Rojo M; Abruzzese GA; Cocucci SE; Iglesias Molli AE; Frechtel GD; Motta AB; Cerrone GE
    Front Endocrinol (Lausanne); 2021; 12():604215. PubMed ID: 34054718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Physical Resistance Training on the Sexual Function of Women with Polycystic Ovary Syndrome.
    Lara LA; Ramos FK; Kogure GS; Costa RS; Silva de Sá MF; Ferriani RA; dos Reis RM
    J Sex Med; 2015 Jul; 12(7):1584-90. PubMed ID: 25982537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Body composition and polycystic ovary syndrome].
    Zabuliene L; Tutkuviene J
    Medicina (Kaunas); 2010; 46(2):142-57. PubMed ID: 20440089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive resistance training in polycystic ovary syndrome: can pumping iron improve clinical outcomes?
    Cheema BS; Vizza L; Swaraj S
    Sports Med; 2014 Sep; 44(9):1197-207. PubMed ID: 24872311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome.
    Costa EC; Sá JC; Soares EM; Lemos TM; Maranhão TM; Azevedo GD
    Gynecol Endocrinol; 2012 Jan; 28(1):12-5. PubMed ID: 21958393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polycystic ovary syndrome per se is not associated with increased chronic inflammation.
    Möhlig M; Spranger J; Osterhoff M; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Eur J Endocrinol; 2004 Apr; 150(4):525-32. PubMed ID: 15080783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome.
    Pedroso DC; Miranda-Furtado CL; Kogure GS; Meola J; Okuka M; Silva C; Calado RT; Ferriani RA; Keefe DL; dos Reis RM
    Fertil Steril; 2015 Feb; 103(2):542-7.e2. PubMed ID: 25467041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
    PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.